[Trabecular bone score in rheumatology : Are there benefits in comparison to bone densitometry alone?]
- PMID: 37646845
- DOI: 10.1007/s00393-023-01407-5
[Trabecular bone score in rheumatology : Are there benefits in comparison to bone densitometry alone?]
Abstract
Patients with inflammatory rheumatic diseases have an increased risk of fractures due to the inflammatory potential of the disease and also because of the treatment with glucocorticoids that is often necessary. According to the current guidelines of the Governing Body on Osteology (DVO), the fracture risk can be assessed using dual energy X‑ray absorptiometry and can also be supplemented by measuring the trabecular bone score (TBS). The assessment of the TBS offers additional advantages, for example in glucocorticoid-induced osteoporosis and in patients with osteoproliferative changes of the spine (spondylarthritis) and thus optimizes the fracture risk assessment in the rheumatological patient population.
Patient*innen mit entzündlich rheumatischen Erkrankungen weisen aufgrund des Entzündungspotenzials ihrer Erkrankung, aber auch wegen der oft notwendigen Glukokortikoidbehandlung ein erhöhtes Frakturrisiko auf. Die Abschätzung des Frakturrisikos erfolgt nach aktueller DVO(Dachverband Osteologie)-Leitlinie auch mittels „dual-energy X‑ray absorptiometry“, diese kann auch durch die Bestimmung des Trabecular Bone Score (TBS) ergänzt werden. Die Erhebung von TBS bringt zusätzliche Vorteile z. B. bei der Glukokortikoid-induzierten Osteoporose, aber auch bei Patient*innen mit osteoproliferativen Veränderungen an der Wirbelsäule (Spondylarthritiden) und optimiert somit im rheumatologischen Patientengut die Frakturrisikoabschätzung.
Keywords: Bone; Bone density; Densitometry, bone; Dual-energy X‑ray absorptiometry; Fractures.
© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
References
Literatur
-
- Konnopka A, Jerusel N, König HH (2009) The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050. Osteoporos Int 20(7):1117–1129 - PubMed
-
- Rossini M, Viapiana O, Vitiello M, Malavolta N, La Montagna G, Maddali Bongi S et al (2017) Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. Reumatismo 69(1):30–39 - PubMed
-
- Cetin B, Cetin EA, Arikan H, Velioglu A, Alibaz-Oner F, Direskeneli H et al (2021) FRAX scores are increased in patients with ANCA-associated vasculitis. Int Urol Nephrol 53(11):2333–2339 - PubMed
-
- Chen J, Lei L, Pan J, Zhao C (2020) A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis. Clin Rheumatol 39(4):1181–1189 - PubMed
-
- Molto A, Etcheto A, van der Heijde D, Landewe R, van den Bosch F, Bautista Molano W et al (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75(6):1016–1023 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
